These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36716692)

  • 41. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
    Kennedy S; Beaudoin T; Yau YC; Caraher E; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
    Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential energy surfaces of carrageenan models: carrabiose, beta-(1 --> 4)-linked D-galactobiose, and their sulfated derivatives.
    Stortz CA
    Carbohydr Res; 2002 Nov; 337(21-23):2311-23. PubMed ID: 12433495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence.
    Silva IN; Ferreira AS; Becker JD; Zlosnik JEA; Speert DP; He J; Mil-Homens D; Moreira LM
    Microbiology (Reading); 2011 Nov; 157(Pt 11):3124-3137. PubMed ID: 21835880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MM3 potential energy surfaces of the 2-linked glucosyl trisaccharides alpha-kojitriose and beta-sophorotriose.
    Stortz CA; Cerezo AS
    Carbohydr Res; 2003 Jul; 338(16):1679-89. PubMed ID: 12873423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MM3 potential energy surfaces of trisaccharides. II. Carrageenan models containing 3,6-anhydro-D-galactose.
    Stortz CA; Cerezo AS
    Biopolymers; 2003 Oct; 70(2):227-39. PubMed ID: 14517911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macromolecular and solution properties of Cepacian: the exopolysaccharide produced by a strain of Burkholderia cepacia isolated from a cystic fibrosis patient.
    Sist P; Cescutti P; Skerlavaj S; Urbani R; Leitão JH; Sá-Correia I; Rizzo R
    Carbohydr Res; 2003 Sep; 338(18):1861-7. PubMed ID: 12932369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing.
    Baldwin A; Mahenthiralingam E; Drevinek P; Pope C; Waine DJ; Henry DA; Speert DP; Carter P; Vandamme P; LiPuma JJ; Dowson CG
    J Clin Microbiol; 2008 Jan; 46(1):290-5. PubMed ID: 18032622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-Term Evolution of
    Silva IN; Santos PM; Santos MR; Zlosnik JE; Speert DP; Buskirk SW; Bruger EL; Waters CM; Cooper VS; Moreira LM
    mSystems; 2016; 1(3):. PubMed ID: 27822534
    [No Abstract]   [Full Text] [Related]  

  • 49. Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms.
    Forier K; Messiaen AS; Raemdonck K; Nelis H; De Smedt S; Demeester J; Coenye T; Braeckmans K
    J Control Release; 2014 Dec; 195():21-8. PubMed ID: 25125326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of a disaccharide repeating unit of the O-antigen from Burkholderia ambifaria and its oligomers.
    Wang D; Zhuge W; Guo Z; Gu G
    Carbohydr Res; 2017 Apr; 442():41-51. PubMed ID: 28288346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The biofilm of Burkholderia cenocepacia H111 contains an exopolysaccharide composed of l-rhamnose and l-mannose: Structural characterization and molecular modelling.
    Bellich B; Jou IA; Buriola C; Ravenscroft N; Brady JW; Fazli M; Tolker-Nielsen T; Rizzo R; Cescutti P
    Carbohydr Res; 2021 Jan; 499():108231. PubMed ID: 33440288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solution conformation and dynamics of exopolysaccharides from Burkholderia species.
    Pol-Fachin L; Serrato RV; Verli H
    Carbohydr Res; 2010 Sep; 345(13):1922-31. PubMed ID: 20633874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomics of an endemic cystic fibrosis Burkholderia multivorans strain reveals low within-patient evolution but high between-patient diversity.
    Lood C; Peeters C; Lamy-Besnier Q; Wagemans J; De Vos D; Proesmans M; Pirnay JP; Echahidi F; Piérard D; Thimmesch M; Boeras A; Lagrou K; De Canck E; De Wachter E; van Noort V; Lavigne R; Vandamme P
    PLoS Pathog; 2021 Mar; 17(3):e1009418. PubMed ID: 33720991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosis.
    Moore JE; Xu J; Millar BC; Crowe M; Elborn JS
    J Microbiol Methods; 2002 Apr; 49(2):183-91. PubMed ID: 11830304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of liposomes formed by lipopolysaccharides from Burkholderia cenocepacia, Burkholderia multivorans and Agrobacterium tumefaciens: from the molecular structure to the aggregate architecture.
    D'Errico G; Silipo A; Mangiapia G; Vitiello G; Radulescu A; Molinaro A; Lanzetta R; Paduano L
    Phys Chem Chem Phys; 2010 Nov; 12(41):13574-85. PubMed ID: 20852798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Draft genome sequence determination for cystic fibrosis and chronic granulomatous disease Burkholderia multivorans isolates.
    Varga JJ; Losada L; Zelazny AM; Brinkac L; Harkins D; Radune D; Hostetler J; Sampaio EP; Ronning CM; Nierman WC; Greenberg DE; Holland SM; Goldberg JB
    J Bacteriol; 2012 Nov; 194(22):6356-7. PubMed ID: 23105085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients.
    De Boeck K; Malfroot A; Van Schil L; Lebecque P; Knoop C; Govan JR; Doherty C; Laevens S; Vandamme P;
    Eur Respir J; 2004 Jun; 23(6):851-6. PubMed ID: 15218997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stress conditions triggering mucoid morphotype variation in Burkholderia species and effect on virulence in Galleria mellonella and biofilm formation in vitro.
    Silva IN; Tavares AC; Ferreira AS; Moreira LM
    PLoS One; 2013; 8(12):e82522. PubMed ID: 24358195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of two distinct phylogenomic lineages and model strains for the understudied cystic fibrosis lung pathogen
    Parfitt KM; Green AE; Connor TR; Neill DR; Mahenthiralingam E
    Microbiology (Reading); 2023 Aug; 169(8):. PubMed ID: 37526960
    [No Abstract]   [Full Text] [Related]  

  • 60. Structure of a novel exopolysaccharide produced by Burkholderia vietnamiensis, a cystic fibrosis opportunistic pathogen.
    Cescutti P; Cuzzi B; Herasimenka Y; Rizzo R
    Carbohydr Polym; 2013 Apr; 94(1):253-60. PubMed ID: 23544536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.